News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,656 Results
Type
Article (1364)
Company Profile (4)
Press Release (7288)
Section
Business (3548)
Career Advice (10)
Deals (484)
Drug Delivery (4)
Drug Development (1672)
Employer Resources (4)
FDA (263)
Job Trends (295)
News (5901)
Policy (541)
Tag
Academia (20)
Adcomms (3)
Allergies (1)
Alliances (1027)
ALS (2)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (11)
Approvals (258)
Artificial intelligence (7)
Autoimmune disease (3)
Bankruptcy (5)
Best Places to Work (152)
BIOSECURE Act (1)
Biotechnology (2)
Breast cancer (3)
Cancer (44)
Cardiovascular disease (6)
Career advice (10)
Cell therapy (4)
Clinical research (1372)
Collaboration (16)
Compensation (3)
COVID-19 (115)
CRISPR (2)
C-suite (8)
Data (24)
Denatured (2)
Diabetes (1)
Diagnostics (26)
Diversity, equity & inclusion (2)
Drug discovery (2)
Drug pricing (4)
Duchenne muscular dystrophy (2)
Earnings (1018)
Editorial (3)
Employer branding (2)
Employer resources (4)
Events (713)
Executive appointments (31)
FDA (271)
Frontotemporal dementia (1)
Funding (10)
Gene editing (3)
Gene therapy (3)
GLP-1 (15)
Government (69)
Healthcare (187)
Immunology and inflammation (12)
Infectious disease (148)
Inflammatory bowel disease (2)
Inflation Reduction Act (1)
Intellectual property (1)
IPO (131)
IRA (2)
Job creations (146)
Job search strategy (9)
Labor market (1)
Layoffs (23)
Leadership (1)
Legal (149)
Liver cancer (1)
Lung cancer (8)
Machine learning (1)
Management (1)
Manufacturing (6)
Medical device (16)
Medtech (16)
Mergers & acquisitions (356)
Metabolic disorders (9)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (19)
NextGen: Class of 2025 (77)
Non-profit (31)
Obesity (7)
Opinion (12)
Ovarian cancer (4)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Patents (12)
People (1310)
Pharmaceutical (2)
Phase I (353)
Phase II (554)
Phase III (563)
Pipeline (36)
Policy (7)
Postmarket research (97)
Preclinical (105)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (9)
Real estate (76)
Regulatory (370)
Reports (2)
Research institute (27)
Resumes & cover letters (1)
RNA editing (1)
RSV (24)
Series A (3)
Series B (1)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (105)
Stomach cancer (3)
Supply chain (2)
Tariffs (1)
The Weekly (9)
Vaccines (92)
Venture capitalists (3)
Weight loss (5)
Date
Today (2)
Last 7 days (12)
Last 30 days (31)
Last 365 days (497)
2025 (152)
2024 (497)
2023 (532)
2022 (727)
2021 (607)
2020 (516)
2019 (409)
2018 (331)
2017 (401)
2016 (429)
2015 (658)
2014 (462)
2013 (384)
2012 (337)
2011 (394)
2010 (385)
Location
Africa (36)
Asia (567)
Australia (171)
California (63)
Canada (22)
China (16)
Colorado (1)
Connecticut (2)
Europe (3122)
Florida (1)
Georgia (2)
Illinois (12)
Indiana (3)
Japan (3)
Maryland (3)
Massachusetts (59)
New Hampshire (2)
New Jersey (25)
New York (7)
North Carolina (7)
Northern California (26)
Pennsylvania (16)
South America (22)
Southern California (19)
Texas (18)
United States (218)
Utah (3)
Virginia (1)
Washington D.C. (3)
Washington State (6)
Wisconsin (1)
8,656 Results for "gsk".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
GSK Optimistic About M&A Prospects Despite Trump Tariff Threats
GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for “opportunities created” amid these tensions, according to CEO Emma Walmsley. The company also reported a 4% earnings bump for the quarter.
April 30, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Vaccines
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” experiment to determine whether 65- and 66-year-olds who received GSK’s shingles vaccine Shingrix have reduced dementia risk.
March 25, 2025
·
1 min read
·
Dan Samorodnitsky
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and ViiV will push forward with their long-acting antivirals after touting positive early-stage results.
March 12, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
GSK Targets Rare Cancer With $1B+ Acquisition of IDRx
The first major deal of JPM 2025 will give GSK a promising small molecule drug for gastrointestinal stromal tumors.
January 13, 2025
·
2 min read
·
Tristan Manalac
Vaccines
GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome Warnings
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo, prompting the regulator to require adjustments to the vaccines’ labels.
January 8, 2025
·
2 min read
·
Tristan Manalac
Ovarian cancer
GSK Posts Mixed Survival Data for Jemperli/Zejula Combo in First-Line Ovarian Cancer
First approved in 2021, Jemperli has now become a cornerstone of GSK’s cancer business, earning more than $160 million in the third quarter.
December 20, 2024
·
2 min read
·
Tristan Manalac
Press Releases
GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices
April 17, 2025
·
12 min read
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
The Muna partnership will give GSK access to Muna’s MiND-MAP platform, which it will apply to postmortem brain samples to identify potential therapeutic targets for Alzheimer’s disease.
December 5, 2024
·
2 min read
·
Tristan Manalac
Policy
GSK Quits Trade Group BIO as Industry Faces Uncertain Political Future
GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug price negotiation program.
November 11, 2024
·
2 min read
·
Tristan Manalac
1 of 866
Next
